These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16179864)

  • 1. Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma.
    Ilmonen S; Hernberg M; Pyrhönen S; Tarkkanen J; Asko-Seljavaara S
    Melanoma Res; 2005 Oct; 15(5):375-81. PubMed ID: 16179864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-protein and Ki-67-antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin.
    Vogt T; Zipperer KH; Vogt A; Hölzel D; Landthaler M; Stolz W
    Histopathology; 1997 Jan; 30(1):57-63. PubMed ID: 9023558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion.
    Bubb RS; Komaki R; Hachiya T; Milas I; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1216-24. PubMed ID: 12128123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
    Moul JW; Bettencourt MC; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Bauer JJ
    Surgery; 1996 Aug; 120(2):159-66; discussion 166-7. PubMed ID: 8751578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of biomarkers in malignant melanoma.
    Hernberg M; Turunen JP; von Boguslawsky K; Muhonen T; Pyrhönen S
    Melanoma Res; 1998 Jun; 8(3):283-91. PubMed ID: 9664152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD40, CD44, bcl-2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma.
    Sviatoha V; Rundgren A; Tani E; Hansson J; Kleina R; Skoog L
    Cytopathology; 2002 Feb; 13(1):11-21. PubMed ID: 11985564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma.
    Straume O; Sviland L; Akslen LA
    Clin Cancer Res; 2000 May; 6(5):1845-53. PubMed ID: 10815907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma.
    Llanos M; Alvarez-Argüelles H; Alemán R; Oramas J; Diaz-Flores L; Batista N
    Med Oncol; 2001; 18(1):15-22. PubMed ID: 11778965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging.
    Robinson EM; Rosenbaum BE; Zhang Y; Rogers R; Tchack J; Berman RS; Darvishian F; Osman I; Shapiro RL; Shao Y; Polsky D
    J Surg Oncol; 2018 Jul; 118(1):150-156. PubMed ID: 29878361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of P53 protein in cutaneous melanoma].
    Casazza S; Gambini C; Tunesi G; Rovida S; Caruso F; Pastorino A; Canepa M
    Pathologica; 1993; 85(1097):335-42. PubMed ID: 8233650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.
    Nakopoulou L; Vourlakou C; Zervas A; Tzonou A; Gakiopoulou H; Dimopoulos MA
    Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications.
    Weiss J; Heine M; Körner B; Pilch H; Jung EG
    Br J Dermatol; 1995 Jul; 133(1):23-31. PubMed ID: 7669636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
    Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome.
    Lawrence NF; Hammond MR; Frederick DT; Su Y; Dias-Santagata D; Deng A; Selim MA; Mahalingam M; Flaherty KT; Hoang MP
    J Am Acad Dermatol; 2016 Sep; 75(3):595-602. PubMed ID: 27543214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
    Flørenes VA; Maelandsmo GM; Faye R; Nesland JM; Holm R
    J Pathol; 2001 Dec; 195(5):530-6. PubMed ID: 11745687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of regulators of cell cycle and apoptosis, p16(INK4a), p53, and bcl-2 in primary mucosal melanomas of the head and neck.
    Prasad ML; Patel SG; Shah JP; Hoshaw-Woodard S; Busam KJ
    Head Neck Pathol; 2012 Jun; 6(2):184-90. PubMed ID: 22160615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting.
    Borre M; Stausbol-Gron B; Overgaard J
    J Urol; 2000 Sep; 164(3 Pt 1):716-21. PubMed ID: 10953132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-67 and p53 expression in head and neck mucosal melanoma: A clinicopathologic analysis of predictors of outcome.
    Yin G; Guo W; Liu H; Huang Z; Chen X
    Ann Diagn Pathol; 2021 Oct; 54():151789. PubMed ID: 34304143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.